13F Filings History of Clarus Ventures, LLC

Latest 13F report
Q3 2018 - 14 Nov 2018
Signature - Title
Robert W. Liptak - Managing Director
Location
Cambridge, MA
Summary
This page shows a list of all the recent 13F filings made by Clarus Ventures, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Clarus Ventures, LLC reported 10 stock holdings with total value $5,006 as of Q3 2018.

Notify me when Clarus Ventures, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 $0 13F-NT 14 Nov 2025, 16:01
Q2 2025 $0 13F-NT 14 Aug 2025, 16:18
Q1 2025 $0 13F-NT 15 May 2025, 17:15
Q4 2024 $0 13F-NT 14 Feb 2025, 16:05
Q3 2024 $0 13F-NT 14 Nov 2024, 16:05
Q2 2024 $0 13F-NT 14 Aug 2024, 16:05
Q1 2024 $0 13F-NT 15 May 2024, 16:05
Q4 2023 $0 13F-NT 14 Feb 2024, 16:06
Q3 2023 0 $0 13F-NT 14 Nov 2023, 17:01
Q2 2023 0 $0 13F-NT 14 Aug 2023, 16:15
Q1 2023 0 $0 13F-NT 15 May 2023, 16:05
Q4 2022 0 $0 13F-NT 14 Feb 2023, 15:52
Q3 2022 0 $0 13F-NT 14 Nov 2022, 15:37
Q2 2022 0 $0 13F-NT 15 Aug 2022, 17:03
Q1 2022 0 $0 13F-NT 16 May 2022, 16:44
Q4 2021 0 $0 13F-NT 14 Feb 2022, 16:01
Q3 2021 0 $0 13F-NT 15 Nov 2021, 16:06
Q2 2021 0 $0 13F-NT 16 Aug 2021, 17:15
Q1 2021 0 $0 13F-NT 17 May 2021, 17:01
Q4 2020 0 $0 13F-NT 16 Feb 2021, 15:55
Q3 2020 0 $0 13F-NT 16 Nov 2020, 15:50
Q2 2020 0 $0 13F-NT 14 Aug 2020, 15:50
Q1 2020 0 $0 13F-NT 15 May 2020, 17:14
Q4 2019 0 $0 13F-NT 14 Feb 2020, 15:42
Q3 2019 0 $0 13F-NT 14 Nov 2019, 15:40
Q2 2019 0 $0 13F-NT 14 Aug 2019, 17:11
Q1 2019 0 $0 13F-NT 15 May 2019, 16:21
Q4 2018 0 $0 13F-NT 14 Feb 2019, 11:56
Q3 2018 10 $5,006 $0 $0 $0 EPIX 13F-HR 14 Nov 2018, 10:04
Q2 2018 8 $281,152,000 +$151,998,000 -$6,374,000 +$145,624,000 AVRO, FTSV, NSTGQ, SIEN, HAIR 13F-HR 14 Aug 2018, 15:50
Q1 2018 6 $97,783,000 +$5,968,842 -$1,347,240 +$4,621,602 NSTGQ, SIEN, HAIR, VBIV, ESSA Pharma Inc. 13F-HR 25 Apr 2018, 10:36
Q4 2017 6 $100,450,000 +$16,422,000 $0 +$16,422,000 SIEN, NSTGQ, HAIR, VBIV, CATB 13F-HR 12 Feb 2018, 15:31
Q3 2017 5 $122,849,000 $0 $0 $0 NSTGQ, SIEN, VBIV, CATB, ESSA Pharma Inc. 13F-HR 13 Nov 2017, 09:56
Q2 2017 5 $108,786,000 $0 -$6,895,000 -$6,895,000 NSTGQ, SIEN, VBIV, CATB, ESSA Pharma Inc. 13F-HR 03 Aug 2017, 16:58
Q1 2017 6 $134,358,000 $0 -$11,065,820 -$11,065,820 NSTGQ, SIEN, VBIV, OXFD, ESSA Pharma Inc. 13F-HR 09 May 2017, 13:57
Q4 2016 6 $151,819,000 $0 -$14,854,976 -$14,854,976 NSTGQ, SIEN, OXFD, CATB, VBIV 13F-HR 13 Feb 2017, 14:04
Q3 2016 6 $162,721,000 $0 $0 $0 NSTGQ, OXFD, SIEN, CATB, VBIV 13F-HR 09 Nov 2016, 17:22
Q2 2016 6 $114,306,000 +$10,630,000 -$12,157,000 -$1,527,000 NSTGQ, OXFD, SIEN, VBIV, CATB 13F-HR 04 Aug 2016, 13:06
Q1 2016 6 $133,202,000 +$7,368,533 -$9,569,000 -$2,200,467 NSTGQ, OXFD, SIEN, CATB, VBIV 13F-HR 22 Apr 2016, 11:36
Q4 2015 7 $142,695,000 $0 -$8,646,000 -$8,646,000 NSTGQ, OXFD, CATB, SIEN, VBIV 13F-HR 25 Jan 2016, 16:46
Q3 2015 8 $173,884,000 +$1,118,000 -$192,849 +$925,151 NSTGQ, OXFD, SIEN, CATB, VBIV 13F-HR 12 Nov 2015, 14:56
Q2 2015 7 $227,411,000 +$33,608,000 -$75,166,705 -$41,558,705 SIEN, NSTGQ, CATB, OXFD, VBIV 13F-HR 30 Jul 2015, 14:51
Q1 2015 7 $240,546,000 $0 -$100,362,869 -$100,362,869 OPHT, SIEN, NSTGQ, OXFD, TLOG 13F-HR 12 May 2015, 14:39
Q4 2014 8 $350,285,000 +$53,863,000 -$3,807,186 +$50,055,814 AERI, OPHT, NSTGQ, SIEN, OXFD 13F-HR 12 Feb 2015, 17:19
Q3 2014 6 $250,614,000 +$16,305,000 $0 +$16,305,000 AERI, OPHT, NSTGQ, OXFD, TLOG 13F-HR 13 Nov 2014, 13:42
Q2 2014 5 $27,357 $0 $0 $0 TLOG 13F-HR 12 Aug 2014, 11:25
Q1 2014 5 $0 $0 $0 $0 13F-HR 09 May 2014, 15:56
Q4 2013 6 $353,882,000 $0 $0 $0 OPHT, NSTGQ, AERI, OXFD, TLOG 13F-HR 14 Feb 2014, 16:02